LEIDOS BIOMEDICAL RESEARCH INC

Federal contract award, Leidos, $56,499,671

Key CONT_AWD_75N91020F00026_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 345 days before this system saw it. One version on record.

Cite this row

On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91020F00026_7529_75N91019D00024_7529
At the source https://www.usaspending.gov/award/CONT_AWD_75N91020F00026_7529_75N91019D00024_7529
Observed 2026-09-05, version 1, retrieved 2026-09-05T00:54:32Z
Content hash a5042734e3b7dcdcb0e0d0bdc4930e4e4aaf2f7b5c46fa86e6f395bd68554cd7

The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.

Versions

VersionAmountChangeOccurredPublishedRetrievedHow it arrivedContent hash
1
current
$56,499,671first versionSeptember 28, 2020September 25, 20252026-09-05T00:54:32Zhistorical sweepa5042734e3b7

Archived copy

https://web.archive.org/web/20261010235827/https://www.usaspending.gov/award/CONT_AWD_75N91020F00026_7529_75N91019D00024_7529 captured by this system, October 10, 2026

What the amount is made of

9 recorded actions, so the amount is the award's current total across all of them. 3 of them obligated money. Measured 2026-10-13, when USAspending reported a total obligation of $56,499,671.

Action dateModificationTypeObligatedDescription as recorded
September 25, 2025P00008EXERCISE AN OPTION+$17,488,492DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
September 11, 2025P00007OTHER ADMINISTRATIVE ACTION−$1,995,955EIO:: IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
April 25, 2025P00006TERMINATE FOR CONVENIENCE (COMPLETE OR PARTIAL)no moneyEOI::IMPLEMENTING THE PRESIDENTS DEPARTMENT OF GOVERNMENT EFFICIENCY COST EFFICIENCY INITIATIVE (MARCH 19, 2025)::EOI
December 12, 2024P00005OTHER ADMINISTRATIVE ACTIONno moneyDEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
May 21, 2024P00004OTHER ADMINISTRATIVE ACTIONno moneyDEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
June 23, 2023P00003OTHER ADMINISTRATIVE ACTIONno moneyDEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
May 25, 2023P00002OTHER ADMINISTRATIVE ACTIONno moneyDEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
November 8, 2022P00001OTHER ADMINISTRATIVE ACTIONno moneyDEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS
September 28, 2020basenot on file+$41,007,134DEVELOPMENT OF TARGET CHARACTERIZATION METHODS FOR NOVEL CANCER MARKERS

Last refreshed November 4, 2026 at 2:31 PM UTC.